Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine versus sertraline for depression in hemodialysis patients
IRCT20120215009014N445Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mirtazapine and sertraline in major depressive disorder (MDD) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Change in depression symptoms. Started Nov 2022; status: completed.
02
Drugs
mirtazapinesertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20120215009014N445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N445.